US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

23.61

-1.0100-4.10%

Pre-market: 23.40-0.2100-0.89%06:45 EDT

Volume:775.94K

Turnover:18.50M

Market Cap:1.95B

PE:-10.31

High:24.51

Open:24.00

Low:23.52

Close:24.62

52wk High:47.65

52wk Low:10.44

Shares:82.40M

Float Shares:60.57M

Volume Ratio:0.51

T/O Rate:1.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2900

EPS(LYR):-2.2900

ROE:-36.91%

ROA:-24.58%

PB:3.01

PE(LYR):-10.31

Loading ...

Overview Company News Filings

Mineralys Therapeutics Reports Inducement Equity Awards Under Nasdaq Rule 5635(c)(4)

Mineralys Therapeutics Chief Medical Officer David Malcom Rodman Reports Common Share Disposal

Mineralys Therapeutics Grants Inducement Equity Awards to New Employees

Press Release: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Chief Medical Officer David Malcom Rodman Sells Common Shares of Mineralys Therapeutics Inc

Mineralys Therapeutics Inc call volume above normal and directionally bullish

Chief Medical Officer David Malcom Rodman Reports Sale of Mineralys Therapeutics Inc. Common Shares

Mineralys Therapeutics (MLYS) Valuation After Q3 Beat And Lorundrostat NDA Progress

Simply Wall St.

Mineralys Therapeutics CEO Jon Congleton Reports Disposal of Common Shares

CFO Adam Scott Levy Sells Common Shares of Mineralys Therapeutics Inc

Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch

Mineralys Therapeutics Inc - Filed Nda for Lorundrostat to U.S. FDA in Late 2025

THOMSON REUTERS

Mineralys Therapeutics Inc - Co Remains on Track to Report Topline Results From Phase 2 Explore-Osa Trial in Q1 2026

THOMSON REUTERS

Mineralys Therapeutics Submits NDA for Lorundrostat to FDA

Did JAMA’s “Research of the Year” Spotlight on Lorundrostat Just Shift Mineralys Therapeutics’ (MLYS) Investment Narrative?

Simply Wall St.

Mineralys Therapeutics Inc : Bofa Global Research Raises Price Objective to $46 From $43

THOMSON REUTERS

How Investors May Respond To Mineralys Therapeutics (MLYS) After $287.5 Million Upsized Capital Raise and New Institutional Backing

Simply Wall St.

BRIEF-Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)

Director and 10% Owner Brian Taylor Slingsby Reports Disposal of Mineralys Therapeutics Inc. Common Shares

Mineralys Therapeutics Q3 EPS USD -0.52

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MLYS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MLYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":23.61,"timestamp":1774555200000,"preClose":24.62,"halted":0,"volume":775936,"hourTrading":{"tag":"盘前","latestPrice":23.4,"preClose":23.61,"latestTime":"06:45 EDT","volume":189,"amount":4481.399979,"timestamp":1774608349244,"change":-0.21,"changeRate":-0.008895,"amplitude":0.025413},"delay":0,"changeRate":-0.041023558082859526,"floatShares":60570600,"shares":82399500,"eps":-2.29,"marketStatus":"Pre-Mkt","change":-1.01,"latestTime":"03-27 08:34:19 EDT","open":24,"high":24.51,"low":23.5225,"amount":18497023.858432,"amplitude":0.04011,"askPrice":24.99,"askSize":17,"bidPrice":22.11,"bidSize":17,"shortable":3,"etf":0,"ttmEps":-2.29,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774618200000},"marketStatusCode":1,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":23.61,"preHourTrading":{"tag":"盘前","latestPrice":23.4,"preClose":23.61,"latestTime":"06:45 EDT","volume":189,"amount":4481.399979,"timestamp":1774608349244,"change":-0.21,"changeRate":-0.008895,"amplitude":0.025413},"postHourTrading":{"tag":"盘后","latestPrice":23.61,"preClose":23.61,"latestTime":"17:30 EDT","volume":36744,"amount":867525.84,"timestamp":1774560638414,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5093681580329485,"impliedVol":0.7625,"impliedVolPercentile":0.404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","floatShares":60570600,"roa":"-24.58%","roe":"-36.91%","lyrEps":-2.29,"volumeRatio":0.5093681580329485,"shares":82399500,"dividePrice":0,"high":24.51,"amplitude":0.04011,"preClose":24.62,"low":23.5225,"week52Low":10.44,"pbRate":"3.01","week52High":47.65,"institutionHeld":0,"latestPrice":23.61,"eps":-2.29,"divideRate":0,"volume":775936,"delay":0,"ttmEps":-2.29,"open":24,"prevYearClose":36.29,"prevWeekClose":24.07,"prevMonthClose":29.26,"prevQuarterClose":36.29,"fiveDayClose":23.28,"twentyDayClose":29.03,"sixtyDayClose":36.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MLYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-12","symbol":"MLYS","fiscalQuarterEnding":"2025/12","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2025-11-10","symbol":"MLYS","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2025-08-12","symbol":"MLYS","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MLYS","fiscalQuarterEnding":"2025/03","expectedEps":-1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2025-02-12","symbol":"MLYS","fiscalQuarterEnding":"2024/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MLYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MLYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1756958400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MLYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MLYS","date":"2026-03-26","current":-10.310044,"percent":0.332474,"low":-28.120261,"twenty":-16.70426,"median":-7.890124,"eighty":-4.920533,"high":-2.455206,"avg":-10.35732,"sd":6.120488,"marketCap":2028675148},"quantilePoints":[{"date":"2023-02-10","current":-25.898259,"twenty":-24.067223,"median":-21.320668,"eighty":-10.744265,"marketCap":720204681},{"date":"2023-02-17","current":-26.342543,"twenty":-26.413064,"median":-26.058397,"eighty":-23.151704,"marketCap":732559788},{"date":"2023-02-24","current":-26.298468,"twenty":-26.483585,"median":-26.320505,"eighty":-25.926348,"marketCap":731334088},{"date":"2023-03-03","current":-28.120261,"twenty":-26.483585,"median":-26.122165,"eighty":-25.407434,"marketCap":781996338},{"date":"2023-03-10","current":-23.918383,"twenty":-26.483585,"median":-26.166241,"eighty":-25.1907,"marketCap":665146310},{"date":"2023-03-17","current":-21.169392,"twenty":-26.45714,"median":-26.078089,"eighty":-23.824355,"marketCap":630826722},{"date":"2023-03-24","current":-20.744359,"twenty":-26.427757,"median":-25.591493,"eighty":-21.169392,"marketCap":618161159},{"date":"2023-03-31","current":-21.471029,"twenty":-26.354297,"median":-24.873355,"eighty":-21.103581,"marketCap":639815185},{"date":"2023-04-06","current":-19.11278,"twenty":-26.342543,"median":-23.918383,"eighty":-20.744359,"marketCap":569541742},{"date":"2023-04-14","current":-18.427243,"twenty":-26.298468,"median":-22.156566,"eighty":-20.113665,"marketCap":549113416},{"date":"2023-04-21","current":-18.879698,"twenty":-26.210316,"median":-21.471029,"eighty":-19.688632,"marketCap":562596111},{"date":"2023-04-28","current":-17.933656,"twenty":-26.122165,"median":-21.24503,"eighty":-18.783722,"marketCap":534405021},{"date":"2023-05-05","current":-20.086243,"twenty":-26.092781,"median":-21.087128,"eighty":-18.674036,"marketCap":598549966},{"date":"2023-05-12","current":-21.992037,"twenty":-26.078089,"median":-21.24503,"eighty":-18.728879,"marketCap":655340714},{"date":"2023-05-19","current":-21.745244,"twenty":-26.038705,"median":-21.457318,"eighty":-18.783722,"marketCap":647986516},{"date":"2023-05-26","current":-16.559387,"twenty":-25.898259,"median":-21.176247,"eighty":-18.591772,"marketCap":576895940},{"date":"2023-06-02","current":-16.969854,"twenty":-25.407434,"median":-21.12826,"eighty":-18.572577,"marketCap":591195768},{"date":"2023-06-09","current":-17.990156,"twenty":-25.1907,"median":-20.744359,"eighty":-18.397637,"marketCap":626741057},{"date":"2023-06-16","current":-18.271619,"twenty":-24.932123,"median":-20.360458,"eighty":-18.2552,"marketCap":636546653},{"date":"2023-06-23","current":-18.869727,"twenty":-24.820464,"median":-20.099954,"eighty":-18.341985,"marketCap":657383546},{"date":"2023-06-30","current":-19.432652,"twenty":-24.438476,"median":-19.960543,"eighty":-18.318529,"marketCap":676994740},{"date":"2023-07-07","current":-18.177798,"twenty":-23.894876,"median":-19.784607,"eighty":-18.295074,"marketCap":633278121},{"date":"2023-07-14","current":-18.224708,"twenty":-23.631036,"median":-19.510392,"eighty":-18.189525,"marketCap":634912387},{"date":"2023-07-21","current":-17.403775,"twenty":-22.844845,"median":-19.344695,"eighty":-18.039908,"marketCap":606312730},{"date":"2023-07-28","current":-16.395201,"twenty":-22.373196,"median":-18.879698,"eighty":-17.903799,"marketCap":571176008},{"date":"2023-08-04","current":-15.996462,"twenty":-22.189472,"median":-18.77395,"eighty":-17.722767,"marketCap":557284746},{"date":"2023-08-11","current":-13.235538,"twenty":-22.153824,"median":-18.728996,"eighty":-17.560925,"marketCap":536039287},{"date":"2023-08-18","current":-12.28726,"twenty":-22.129144,"median":-18.70554,"eighty":-17.406121,"marketCap":497634033},{"date":"2023-08-25","current":-13.043865,"twenty":-22.057849,"median":-18.632904,"eighty":-17.159841,"marketCap":528276523},{"date":"2023-09-01","current":-12.953072,"twenty":-21.986553,"median":-18.590018,"eighty":-16.81974,"marketCap":524599424},{"date":"2023-09-08","current":-11.823209,"twenty":-21.9701,"median":-18.578061,"eighty":-16.550005,"marketCap":478839973},{"date":"2023-09-15","current":-12.055235,"twenty":-21.909773,"median":-18.516678,"eighty":-16.005844,"marketCap":488237003},{"date":"2023-09-21","current":-10.249471,"twenty":-21.805571,"median":-18.455971,"eighty":-13.439317,"marketCap":415103594},{"date":"2023-09-29","current":-9.381898,"twenty":-21.588941,"median":-18.399822,"eighty":-13.144746,"marketCap":379966872},{"date":"2023-10-06","current":-9.926653,"twenty":-21.476513,"median":-18.254027,"eighty":-13.011583,"marketCap":402029465},{"date":"2023-10-13","current":-8.655558,"twenty":-21.471029,"median":-18.201253,"eighty":-12.658501,"marketCap":350550082},{"date":"2023-10-20","current":-8.221771,"twenty":-21.462802,"median":-18.183661,"eighty":-12.299366,"marketCap":332981721},{"date":"2023-10-27","current":-8.12089,"twenty":-21.457318,"median":-18.137991,"eighty":-12.28726,"marketCap":328896056},{"date":"2023-11-03","current":-7.868689,"twenty":-21.320668,"median":-17.990156,"eighty":-12.105675,"marketCap":318681893},{"date":"2023-11-10","current":-5.375877,"twenty":-21.183103,"median":-17.914995,"eighty":-11.823209,"marketCap":304177873},{"date":"2023-11-17","current":-4.874613,"twenty":-21.169392,"median":-17.861152,"eighty":-10.774051,"marketCap":275815341},{"date":"2023-11-24","current":-4.554966,"twenty":-21.169392,"median":-17.720421,"eighty":-10.138503,"marketCap":257729089},{"date":"2023-12-01","current":-4.838289,"twenty":-21.103581,"median":-17.57969,"eighty":-9.743051,"marketCap":273760085},{"date":"2023-12-08","current":-5.012642,"twenty":-21.06519,"median":-17.497596,"eighty":-9.458568,"marketCap":283625314},{"date":"2023-12-15","current":-5.993376,"twenty":-20.807428,"median":-17.409639,"eighty":-9.291106,"marketCap":339117223},{"date":"2023-12-22","current":-5.42673,"twenty":-20.459176,"median":-17.321682,"eighty":-8.792756,"marketCap":307055231},{"date":"2023-12-29","current":-6.225847,"twenty":-20.376911,"median":-17.198542,"eighty":-8.403356,"marketCap":352270861},{"date":"2024-01-05","current":-6.269435,"twenty":-20.360458,"median":-17.051947,"eighty":-8.171331,"marketCap":354737168},{"date":"2024-01-12","current":-6.552758,"twenty":-20.360458,"median":-16.876033,"eighty":-7.818248,"marketCap":370768164},{"date":"2024-01-19","current":-6.007906,"twenty":-20.163024,"median":-16.565251,"eighty":-6.745999,"marketCap":339939325},{"date":"2024-01-26","current":-7.729639,"twenty":-20.091727,"median":-16.395201,"eighty":-6.689335,"marketCap":437358455},{"date":"2024-02-02","current":-9.226167,"twenty":-20.060621,"median":-16.002326,"eighty":-6.745999,"marketCap":522034998},{"date":"2024-02-09","current":-10.192372,"twenty":-19.90434,"median":-13.48774,"eighty":-6.843346,"marketCap":576704805},{"date":"2024-02-16","current":-13.090301,"twenty":-19.80106,"median":-13.291023,"eighty":-7.190598,"marketCap":740675419},{"date":"2024-02-23","current":-13.68452,"twenty":-19.784607,"median":-13.356595,"eighty":-7.398369,"marketCap":774297534},{"date":"2024-03-01","current":-13.439842,"twenty":-19.727022,"median":-13.369934,"eighty":-7.593212,"marketCap":760453134},{"date":"2024-03-08","current":-12.216449,"twenty":-19.581688,"median":-13.356595,"eighty":-7.704554,"marketCap":691231132},{"date":"2024-03-15","current":-11.010534,"twenty":-19.485713,"median":-13.235538,"eighty":-7.770699,"marketCap":622998016},{"date":"2024-03-22","current":-9.036021,"twenty":-19.447295,"median":-13.106761,"eighty":-7.810178,"marketCap":649671871},{"date":"2024-03-28","current":-8.822029,"twenty":-19.362286,"median":-13.087259,"eighty":-7.838424,"marketCap":634286212},{"date":"2024-04-05","current":-8.704678,"twenty":-19.199155,"median":-13.043865,"eighty":-7.874093,"marketCap":625848914},{"date":"2024-04-12","current":-9.049827,"twenty":-19.019547,"median":-12.93794,"eighty":-7.899633,"marketCap":650664494},{"date":"2024-04-19","current":-7.42072,"twenty":-18.87571,"median":-12.8631,"eighty":-7.899633,"marketCap":533534959},{"date":"2024-04-26","current":-7.620907,"twenty":-18.835325,"median":-12.698294,"eighty":-7.82767,"marketCap":547927995},{"date":"2024-05-03","current":-9.036021,"twenty":-18.775904,"median":-12.579814,"eighty":-7.852557,"marketCap":649671871},{"date":"2024-05-10","current":-7.800135,"twenty":-18.750105,"median":-12.324461,"eighty":-7.852557,"marketCap":708236638},{"date":"2024-05-17","current":-7.190448,"twenty":-18.728996,"median":-12.28726,"eighty":-7.795318,"marketCap":652878301},{"date":"2024-05-24","current":-6.68739,"twenty":-18.728949,"median":-12.230329,"eighty":-7.639315,"marketCap":607201644},{"date":"2024-05-31","current":-6.982663,"twenty":-18.724211,"median":-12.17115,"eighty":-7.398356,"marketCap":634011855},{"date":"2024-06-07","current":-7.18498,"twenty":-18.70554,"median":-12.105675,"eighty":-7.206751,"marketCap":652381815},{"date":"2024-06-14","current":-6.878771,"twenty":-18.699239,"median":-12.004794,"eighty":-7.147798,"marketCap":624578633},{"date":"2024-06-21","current":-6.583498,"twenty":-18.674036,"median":-11.801366,"eighty":-7.108428,"marketCap":597768421},{"date":"2024-06-28","current":-6.397585,"twenty":-18.632904,"median":-11.587276,"eighty":-7.004535,"marketCap":580887918},{"date":"2024-07-05","current":-6.796751,"twenty":-18.599998,"median":-11.08918,"eighty":-6.90283,"marketCap":617131352},{"date":"2024-07-12","current":-7.917695,"twenty":-18.591772,"median":-11.014903,"eighty":-6.90283,"marketCap":718910859},{"date":"2024-07-19","current":-7.217788,"twenty":-18.588966,"median":-10.834579,"eighty":-6.932357,"marketCap":655360728},{"date":"2024-07-26","current":-7.354489,"twenty":-18.580102,"median":-10.505451,"eighty":-6.973914,"marketCap":667772863},{"date":"2024-08-02","current":-6.468669,"twenty":-18.558077,"median":-10.192372,"eighty":-6.88752,"marketCap":587342228},{"date":"2024-08-09","current":-6.025759,"twenty":-18.551128,"median":-10.024815,"eighty":-6.843776,"marketCap":547126910},{"date":"2024-08-16","current":-4.076332,"twenty":-18.496301,"median":-9.845949,"eighty":-6.771136,"marketCap":487818681},{"date":"2024-08-23","current":-4.824282,"twenty":-18.473334,"median":-9.694629,"eighty":-6.684109,"marketCap":577326696},{"date":"2024-08-30","current":-5.156705,"twenty":-18.446961,"median":-9.491619,"eighty":-6.64802,"marketCap":617108036},{"date":"2024-09-06","current":-4.666382,"twenty":-18.432727,"median":-9.462603,"eighty":-6.602089,"marketCap":558430560},{"date":"2024-09-13","current":-4.886612,"twenty":-18.41079,"median":-9.366766,"eighty":-6.532417,"marketCap":584785698},{"date":"2024-09-20","current":-4.865835,"twenty":-18.393266,"median":-9.226167,"eighty":-6.400866,"marketCap":582299364},{"date":"2024-09-27","current":-4.944786,"twenty":-18.318529,"median":-9.18084,"eighty":-6.305758,"marketCap":591747432},{"date":"2024-10-04","current":-5.767531,"twenty":-18.250509,"median":-9.070536,"eighty":-6.252,"marketCap":690206249},{"date":"2024-10-11","current":-5.634562,"twenty":-18.229399,"median":-9.042924,"eighty":-6.143869,"marketCap":674293713},{"date":"2024-10-18","current":-5.983606,"twenty":-18.210635,"median":-8.998552,"eighty":-6.048725,"marketCap":716064120},{"date":"2024-10-25","current":-5.655339,"twenty":-18.194216,"median":-8.973895,"eighty":-5.961361,"marketCap":676780046},{"date":"2024-11-01","current":-5.588854,"twenty":-18.189525,"median":-8.92105,"eighty":-5.849535,"marketCap":668823778},{"date":"2024-11-08","current":-5.834016,"twenty":-18.182489,"median":-8.908316,"eighty":-5.825113,"marketCap":698162517},{"date":"2024-11-15","current":-3.728112,"twenty":-18.13003,"median":-8.863447,"eighty":-5.784153,"marketCap":571344320},{"date":"2024-11-22","current":-4.056108,"twenty":-18.054477,"median":-8.834854,"eighty":-5.738445,"marketCap":621610675},{"date":"2024-11-29","current":-4.147037,"twenty":-18.011266,"median":-8.824542,"eighty":-5.694398,"marketCap":635545903},{"date":"2024-12-06","current":-4.289927,"twenty":-17.971392,"median":-8.704678,"eighty":-5.652845,"marketCap":657444117},{"date":"2024-12-13","current":-3.864506,"twenty":-17.93941,"median":-8.597282,"eighty":-5.622096,"marketCap":592247161},{"date":"2024-12-20","current":-4.007395,"twenty":-17.918728,"median":-8.45617,"eighty":-5.566415,"marketCap":614145375},{"date":"2024-12-27","current":-4.163275,"twenty":-17.89399,"median":-8.38318,"eighty":-5.386048,"marketCap":638034336},{"date":"2025-01-03","current":-4.140542,"twenty":-17.884608,"median":-8.283595,"eighty":-5.230583,"marketCap":634550529},{"date":"2025-01-10","current":-3.205267,"twenty":-17.865843,"median":-8.193856,"eighty":-5.186749,"marketCap":491216763},{"date":"2025-01-17","current":-3.000675,"twenty":-17.75795,"median":-8.130978,"eighty":-5.093743,"marketCap":459862501},{"date":"2025-01-24","current":-3.237742,"twenty":-17.725112,"median":-7.972375,"eighty":-5.030384,"marketCap":496193629},{"date":"2025-01-31","current":-3.344909,"twenty":-17.66738,"median":-7.925786,"eighty":-4.98717,"marketCap":512617290},{"date":"2025-02-07","current":-3.185782,"twenty":-17.600622,"median":-7.886161,"eighty":-4.961636,"marketCap":488230642},{"date":"2025-02-14","current":-2.870012,"twenty":-17.57969,"median":-7.841803,"eighty":-4.929578,"marketCap":510316922},{"date":"2025-02-21","current":-2.679426,"twenty":-17.570308,"median":-7.800135,"eighty":-4.913205,"marketCap":476428689},{"date":"2025-02-28","current":-2.56171,"twenty":-17.532779,"median":-7.76156,"eighty":-4.879413,"marketCap":455497722},{"date":"2025-03-07","current":-2.948489,"twenty":-17.497596,"median":-7.666927,"eighty":-4.847705,"marketCap":524270901},{"date":"2025-03-14","current":-5.032788,"twenty":-17.464759,"median":-7.556805,"eighty":-4.833314,"marketCap":894880035},{"date":"2025-03-21","current":-6.142597,"twenty":-17.410812,"median":-7.474785,"eighty":-4.837364,"marketCap":1092215135},{"date":"2025-03-28","current":-5.337906,"twenty":-17.394393,"median":-7.420413,"eighty":-4.839437,"marketCap":949133010},{"date":"2025-04-04","current":-4.515009,"twenty":-17.356865,"median":-7.381829,"eighty":-4.839437,"marketCap":802813733},{"date":"2025-04-11","current":-4.88916,"twenty":-17.298227,"median":-7.359957,"eighty":-4.826979,"marketCap":869341455},{"date":"2025-04-17","current":-4.870916,"twenty":-17.237243,"median":-7.346287,"eighty":-4.83217,"marketCap":866097643},{"date":"2025-04-25","current":-4.867268,"twenty":-17.117621,"median":-7.217788,"eighty":-4.83083,"marketCap":865448881},{"date":"2025-05-02","current":-5.626182,"twenty":-17.049602,"median":-7.174044,"eighty":-4.83217,"marketCap":1000391435},{"date":"2025-05-09","current":-5.345238,"twenty":-17.026147,"median":-7.146704,"eighty":-4.837056,"marketCap":950436740},{"date":"2025-05-16","current":-5.307011,"twenty":-16.932326,"median":-7.108428,"eighty":-4.838863,"marketCap":1000440655},{"date":"2025-05-23","current":-5.642373,"twenty":-16.739993,"median":-7.070152,"eighty":-4.844431,"marketCap":1063660683},{"date":"2025-05-30","current":-5.414189,"twenty":-16.571115,"median":-7.048279,"eighty":-4.857525,"marketCap":1020644994},{"date":"2025-06-06","current":-5.40036,"twenty":-16.559387,"median":-6.993599,"eighty":-4.86168,"marketCap":1018037982},{"date":"2025-06-13","current":-5.158346,"twenty":-16.512477,"median":-6.906111,"eighty":-4.865835,"marketCap":972415282},{"date":"2025-06-20","current":-4.746923,"twenty":-16.418656,"median":-6.878771,"eighty":-4.854252,"marketCap":894856690},{"date":"2025-06-27","current":-4.840271,"twenty":-16.273234,"median":-6.854165,"eighty":-4.839875,"marketCap":912454018},{"date":"2025-07-03","current":-5.026967,"twenty":-16.102011,"median":-6.815889,"eighty":-4.834459,"marketCap":947648672},{"date":"2025-07-11","current":-5.061541,"twenty":-16.001153,"median":-6.774878,"eighty":-4.830927,"marketCap":954166201},{"date":"2025-07-18","current":-4.95782,"twenty":-15.757219,"median":-6.718225,"eighty":-4.834459,"marketCap":934613615},{"date":"2025-07-25","current":-4.930162,"twenty":-14.706714,"median":-6.670986,"eighty":-4.828181,"marketCap":929399592},{"date":"2025-08-01","current":-4.892131,"twenty":-14.028818,"median":-6.651848,"eighty":-4.823763,"marketCap":922230311},{"date":"2025-08-08","current":-4.449592,"twenty":-13.915218,"median":-6.625405,"eighty":-4.809096,"marketCap":838805943},{"date":"2025-08-15","current":-4.827344,"twenty":-13.761419,"median":-6.586232,"eighty":-4.762827,"marketCap":920926805},{"date":"2025-08-22","current":-5.077095,"twenty":-13.590144,"median":-6.552758,"eighty":-4.766426,"marketCap":968572638},{"date":"2025-08-29","current":-5.289075,"twenty":-13.503535,"median":-6.457733,"eighty":-4.786431,"marketCap":1009012700},{"date":"2025-09-05","current":-13.211526,"twenty":-13.468581,"median":-6.485287,"eighty":-4.805659,"marketCap":2520402357},{"date":"2025-09-12","current":-15.109527,"twenty":-13.879712,"median":-6.581817,"eighty":-4.817518,"marketCap":2882489791},{"date":"2025-09-19","current":-16.211433,"twenty":-14.67771,"median":-6.599902,"eighty":-4.819952,"marketCap":3092703659},{"date":"2025-09-26","current":-15.658447,"twenty":-15.194101,"median":-6.643646,"eighty":-4.82127,"marketCap":2987208877},{"date":"2025-10-03","current":-16.451331,"twenty":-15.631718,"median":-6.654582,"eighty":-4.823503,"marketCap":3138469778},{"date":"2025-10-10","current":-16.016261,"twenty":-15.631718,"median":-6.68739,"eighty":-4.825507,"marketCap":3055470207},{"date":"2025-10-17","current":-17.471915,"twenty":-15.790187,"median":-6.743652,"eighty":-4.828719,"marketCap":3333169708},{"date":"2025-10-24","current":-16.593644,"twenty":-16.004913,"median":-6.791282,"eighty":-4.830879,"marketCap":3165619171},{"date":"2025-10-31","current":-16.719692,"twenty":-16.218752,"median":-6.840495,"eighty":-4.833314,"marketCap":3189665776},{"date":"2025-11-07","current":-15.048536,"twenty":-16.218752,"median":-6.86514,"eighty":-4.837364,"marketCap":2870854337},{"date":"2025-11-14","current":-20.454291,"twenty":-16.296821,"median":-6.897909,"eighty":-4.839082,"marketCap":3505108651},{"date":"2025-11-21","current":-19.336671,"twenty":-16.504283,"median":-6.982663,"eighty":-4.840626,"marketCap":3313589957},{"date":"2025-11-28","current":-19.913954,"twenty":-16.568769,"median":-7.015471,"eighty":-4.844431,"marketCap":3412514902},{"date":"2025-12-05","current":-17.969665,"twenty":-16.769708,"median":-7.064684,"eighty":-4.858356,"marketCap":3079335687},{"date":"2025-12-12","current":-16.648841,"twenty":-16.96846,"median":-7.108428,"eighty":-4.862511,"marketCap":2852995413},{"date":"2025-12-19","current":-17.087577,"twenty":-17.041159,"median":-7.14397,"eighty":-4.866122,"marketCap":2928178372},{"date":"2025-12-26","current":-17.286162,"twenty":-17.087577,"median":-7.15764,"eighty":-4.867268,"marketCap":2962208553},{"date":"2026-01-02","current":-16.75968,"twenty":-17.088816,"median":-7.187714,"eighty":-4.870186,"marketCap":2871989003},{"date":"2026-01-09","current":-15.300308,"twenty":-17.059073,"median":-7.271963,"eighty":-4.873874,"marketCap":2621906742},{"date":"2026-01-16","current":-14.492112,"twenty":-17.043505,"median":-7.354489,"eighty":-4.884212,"marketCap":2483411819},{"date":"2026-01-23","current":-15.831409,"twenty":-17.04069,"median":-7.370893,"eighty":-4.887849,"marketCap":2712917691},{"date":"2026-01-30","current":-14.820009,"twenty":-17.021528,"median":-7.392765,"eighty":-4.888966,"marketCap":2539601188},{"date":"2026-02-06","current":-13.028123,"twenty":-17.009066,"median":-7.434083,"eighty":-4.890943,"marketCap":2232538158},{"date":"2026-02-13","current":-12.866483,"twenty":-16.985539,"median":-7.48264,"eighty":-4.894697,"marketCap":2204839174},{"date":"2026-02-20","current":-12.958849,"twenty":-16.967066,"median":-7.595082,"eighty":-4.899313,"marketCap":2220667165},{"date":"2026-02-27","current":-13.40682,"twenty":-16.890615,"median":-7.678432,"eighty":-4.90682,"marketCap":2297432922},{"date":"2026-03-06","current":-12.340001,"twenty":-16.773199,"median":-7.793482,"eighty":-4.913205,"marketCap":2114619624},{"date":"2026-03-13","current":-12.464694,"twenty":-16.743685,"median":-7.809191,"eighty":-4.917335,"marketCap":2135987412},{"date":"2026-03-20","current":-12.403799,"twenty":-16.719061,"median":-7.868689,"eighty":-4.919816,"marketCap":1918259847},{"date":"2026-03-26","current":-13.117763,"twenty":-16.70426,"median":-7.890124,"eighty":-4.920533,"marketCap":2028675148}],"updateTime":1774614859453},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MLYS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614076817","title":"Mineralys Therapeutics Reports Inducement Equity Awards Under Nasdaq Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614076817","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614076817?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:07","pubTimestamp":1772140043,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics said its board compensation committee granted inducement equity awards to a new non-executive employee on Feb. 23, 2026, consisting of stock options covering 27,920 shares and restricted stock units covering 20,940 shares. The option vests over four years with 25% vesting after one year and the remainder vesting monthly thereafter, while the RSUs vest in four equal annual installments over four years. The awards were made under the company’s 2025 Employment Inducement Incentive Award Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL6pFMPb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2612499799","title":"Mineralys Therapeutics Chief Medical Officer David Malcom Rodman Reports Common Share Disposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2612499799","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612499799?lang=en_us&edition=fundamental","pubTime":"2026-02-18 07:57","pubTimestamp":1771372629,"startTime":"0","endTime":"0","summary":"David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL4CZk0B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics Chief Medical Officer David Malcom Rodman Reports Common Share Disposal","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2610960064","title":"Mineralys Therapeutics Grants Inducement Equity Awards to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2610960064","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610960064?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:00","pubTimestamp":1770854451,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Inc. has granted inducement stock option awards covering 33,504 shares and inducement restricted stock unit awards covering 25,128 shares of its common stock to two new non-executive employees. The stock options will vest over four years, with 25% vesting on the first anniversary of the vesting commencement date, February 9, 2026, and the remainder vesting in equal monthly installments thereafter. The restricted stock units will also vest over four years, with 25% vesting on each anniversary of the vesting commencement date. These awards were made under the company’s 2025 Employment Inducement Incentive Award Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDLbJgBCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","MLYS","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","BK4139","BK4588","NDAQ","SG9999014005.SGD","LU0314104364.USD","SG9999014039.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2610960029","title":"Press Release: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610960029","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610960029?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:00","pubTimestamp":1770854400,"startTime":"0","endTime":"0","summary":"RADNOR, Pa., Feb. 11, 2026  -- Mineralys Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease , obstructive sleep apnea  and other diseases driven by dysregulated aldosterone, announced today that on February 9, 2026, the Compensation Committee of Mineralys' Board of Directors granted inducement stock option awards covering 33,504 shares and inducement restricted stock unit awards covering 25,128 shares of Mineralys common stock to two new non-executive employees.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","LENZ","BK4139","BK4007","NQmain","BK4539"],"gpt_icon":0},{"id":"2610960068","title":"Chief Medical Officer David Malcom Rodman Sells Common Shares of Mineralys Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2610960068","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610960068?lang=en_us&edition=fundamental","pubTime":"2026-02-12 07:59","pubTimestamp":1770854366,"startTime":"0","endTime":"0","summary":"David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL7j2891:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Medical Officer David Malcom Rodman Sells Common Shares of Mineralys Therapeutics Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2605209407","title":"Mineralys Therapeutics Inc call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2605209407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605209407?lang=en_us&edition=fundamental","pubTime":"2026-01-24 02:25","pubTimestamp":1769192713,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Mineralys Therapeutics (MLYS) Inc with 1,300 calls trading, 3x expected, and implied vol increasing almost 6 points...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-inc-call-volume-above-normal-and-directionally-bullish-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-inc-call-volume-above-normal-and-directionally-bullish-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","MLYS","BK4539"],"gpt_icon":0},{"id":"2605257171","title":"Chief Medical Officer David Malcom Rodman Reports Sale of Mineralys Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605257171","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605257171?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:34","pubTimestamp":1768959263,"startTime":"0","endTime":"0","summary":"David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics Inc., reported a disposal of common shares of Mineralys Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL43lDGn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Medical Officer David Malcom Rodman Reports Sale of Mineralys Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2604904326","title":"Mineralys Therapeutics (MLYS) Valuation After Q3 Beat And Lorundrostat NDA Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2604904326","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604904326?lang=en_us&edition=fundamental","pubTime":"2026-01-19 08:26","pubTimestamp":1768782367,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) is back in focus after reporting third quarter 2025 earnings that surpassed expectations, updating investors on lorundrostat’s path toward a New Drug Application and expanding its clinical program.\nSee our latest analysis for Mineralys Therapeutics.\nThe latest updates on lorundrostat and Q3 2025 results come after a mixed year in the market, with a 1 day share price return of 4.33% to US$32.74, a 90 day share price return decline of 25.86%, and a 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/mineralys-therapeutics-mlys-valuation-after-q3-beat-and-loru","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/mineralys-therapeutics-mlys-valuation-after-q3-beat-and-loru","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","LU2065732104.USD","PRGS","BK4139","BK4097","MLYS"],"gpt_icon":0},{"id":"2603652774","title":"Mineralys Therapeutics CEO Jon Congleton Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603652774","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603652774?lang=en_us&edition=fundamental","pubTime":"2026-01-14 09:44","pubTimestamp":1768355064,"startTime":"0","endTime":"0","summary":"Jon Congleton, Chief Executive Officer of Mineralys Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL4Y96pm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics CEO Jon Congleton Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2603965277","title":"CFO Adam Scott Levy Sells Common Shares of Mineralys Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2603965277","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603965277?lang=en_us&edition=fundamental","pubTime":"2026-01-14 09:44","pubTimestamp":1768355055,"startTime":"0","endTime":"0","summary":"Adam Scott Levy, Chief Financial Officer and Secretary of Mineralys Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDLc4ZxV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2603636782","title":"Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2603636782","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603636782?lang=en_us&edition=fundamental","pubTime":"2026-01-14 00:30","pubTimestamp":1768321847,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics, Inc. ($MLYS) announced an update on their ongoing clinical study. Mineralys Therapeutics (MLYS) has completed a Phase 2 stu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mineralys-targets-sleep-apnea-and-hypertension-with-lorundrostat-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mineralys-targets-sleep-apnea-and-hypertension-with-lorundrostat-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","ISBC","MLYS","BK4139"],"gpt_icon":0},{"id":"2601974298","title":"Mineralys Therapeutics Inc - Filed Nda for Lorundrostat to U.S. FDA in Late 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2601974298","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601974298?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:12","pubTimestamp":1767705165,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2601889747","title":"Mineralys Therapeutics Inc - Co Remains on Track to Report Topline Results From Phase 2 Explore-Osa Trial in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601889747","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601889747?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:12","pubTimestamp":1767705165,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70CG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2601897664","title":"Mineralys Therapeutics Submits NDA for Lorundrostat to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897664","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601897664?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:01","pubTimestamp":1767704494,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Inc. has filed a New Drug Application  with the U.S. Food and Drug Administration  for lorundrostat, following the successful completion of three positive clinical trials in 2025. The NDA submission marks a key regulatory milestone for the company as it seeks approval for lorundrostat, a drug candidate designed to treat hypertension and related comorbidities. The NDA is supported by data demonstrating lorundrostat’s safety, 24-hour blood pressure control, and efficacy across diverse patient populations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 06, 2026, and is solely responsible for the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL6VVtrJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014021.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","MLYS","BK4588","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014013.SGD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4112","LU2210150020.SGD","NDAQ","BK4139"],"gpt_icon":0},{"id":"2593428124","title":"Did JAMA’s “Research of the Year” Spotlight on Lorundrostat Just Shift Mineralys Therapeutics’ (MLYS) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593428124","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593428124?lang=en_us&edition=fundamental","pubTime":"2025-12-21 17:14","pubTimestamp":1766308473,"startTime":"0","endTime":"0","summary":"In December 2025, Mineralys Therapeutics reported that its Phase 3 Launch-HTN trial of lorundrostat for uncontrolled or treatment-resistant hypertension was featured in JAMA’s inaugural “Research of the Year Roundup” as one of the most impactful studies of the year.\nThis recognition, framed by JAMA as “New Hope for Treatment-Resistant Hypertension,” highlights both the growing clinical interest in aldosterone as a therapeutic target and the breadth of lorundrostat data across four completed...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/did-jamas-research-of-the-year-spotlight-on-lorundrostat-jus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/did-jamas-research-of-the-year-spotlight-on-lorundrostat-jus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2592166156","title":"Mineralys Therapeutics Inc : Bofa Global Research Raises Price Objective to $46 From $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2592166156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592166156?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:29","pubTimestamp":1766143793,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2588722794","title":"How Investors May Respond To Mineralys Therapeutics (MLYS) After $287.5 Million Upsized Capital Raise and New Institutional Backing","url":"https://stock-news.laohu8.com/highlight/detail?id=2588722794","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588722794?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:16","pubTimestamp":1764580578,"startTime":"0","endTime":"0","summary":"In recent news, Findell Capital Management initiated a new US$9.5 million position in Mineralys Therapeutics after the company completed an upsized US$287.5 million capital offering to support ongoing clinical development of lorundrostat for resistant hypertension.\nThis influx of institutional investment reflects increased confidence in Mineralys' financial strength and its progress in advancing pivotal research programs.\nWe'll explore how Mineralys' expanded cash reserves are shaping its...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/how-investors-may-respond-to-mineralys-therapeutics-mlys-aft","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/how-investors-may-respond-to-mineralys-therapeutics-mlys-aft","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","MLYS","BK4139","BK4211"],"gpt_icon":0},{"id":"2586497260","title":"BRIEF-Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586497260","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586497260?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:13","pubTimestamp":1764191608,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)Nov 26 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS REPORTS INDUCEMENT AWARD UNDER NAS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUA62TJT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2585217551","title":"Director and 10% Owner Brian Taylor Slingsby Reports Disposal of Mineralys Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585217551","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585217551?lang=en_us&edition=fundamental","pubTime":"2025-11-22 07:08","pubTimestamp":1763766520,"startTime":"0","endTime":"0","summary":"Brian Taylor Slingsby, a Director and 10% Owner, reported a disposal of common shares of Mineralys Therapeutics Inc. The filing was made by more than one reporting person, including Slingsby and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL5GBThC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director and 10% Owner Brian Taylor Slingsby Reports Disposal of Mineralys Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2584921969","title":"Mineralys Therapeutics Q3 EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584921969?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:15","pubTimestamp":1763572541,"startTime":"0","endTime":"0","summary":"Nov 10 (Reuters) - Mineralys Therapeutics Q3 operating expenses USD 41.131 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 10-NOV-202521:05:47.98 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD6PYypb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":61,"code":"91000000","status":"200"}]}}